Category: Endogenous Stem Cell Activators (1)
Activating Stem Cells of ALS Patients With Valproic Acid
The recent funding of Fate Therapeutics as a company dedicated to identification of pharmacological stem cell activators is a great step for the industry. Essentially, the concept of the company is that one day one will be able to activate one's own stem cells through taking various chemical compounds. This concept is not new, companies such as Stem Cell... Author: Octav Cristea
Affiliation: University of Waterloo
Date Published: Tuesday December 18th, 2007
3 Comments